RecruitingNCT05577143

Blood Screening for Adult Colorectal Cancer

Evaluation of the Discriminatory Role of Blood TFPI-1 and TFPI-2 in Adult Colorectal Cancer

Sponsor

University Hospital, Lille

Enrollment

303 participants

Start Date

Mar 23, 2023

Study Type

OBSERVATIONAL

Conditions

Cancer Colorectal

Summary

Multicenter, inter-regional, case-control study with the primary objective of evaluating the discriminative power of the blood biomarker TFPI-1 to separate patients with histologically proven CRC from an asymptomatic control population between 50 and 75 years of age with normal colonoscopy.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is developing a blood test to help screen for colorectal cancer. Researchers are comparing blood samples from people with confirmed colorectal cancer, polyps, and those with normal colonoscopies to identify markers that could lead to a non-invasive screening tool. **You may be eligible if...** - You are between 50 and 75 years old - You are scheduled for a colonoscopy — either because colorectal cancer is suspected, OR as a routine follow-up procedure - You do not currently have digestive symptoms (the follow-up group) **You may NOT be eligible if...** - You have had a colonoscopy result within a recent timeframe that makes another one unnecessary - You are under 50 or over 75 - You have conditions preventing safe blood collection or colonoscopy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.